An assessment of the survival impact of multimodal anesthesia/analgesia technique in adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score matched analysis

References

• Sugarbaker PH. Management of peritoneal metastases - basic concepts. J Buon. 2015;20(1):S2–S11.
   Google Scholar
• Ung L, Chua TC, Morris DL. Cure for peritoneal metastases? An evidence-based review. ANZ J Surg. 2013;83:821–826.
   PubMed Web of Science ®Google Scholar
• Grotz TE, Royal RE, Mansfield PF, et al. Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade. World J Gastrointest Oncol. 2017;9:354–362.
   PubMed Web of Science ®Google Scholar
• Ronnett BM, Yan H, Kurman RJ, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92:85–91.
   PubMed Web of Science ®Google Scholar
• Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449–2456.
   PubMed Web of Science ®Google Scholar
• Kim R. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence. J Transl Med. 2018;16:8.
   PubMed Web of Science ®Google Scholar
• Byrne K, Levins KJ, Buggy DJ. Can anesthetic-analgesic technique during primary cancer surgery affect recurrence or metastasis? Can J Anesth. 2016;63:184–192.
   PubMed Web of Science ®Google Scholar
• Connolly C, Buggy DJ. Opioids and tumour metastasis: does the choice of the anesthetic-analgesic technique influence outcome after cancer surgery? Curr Opin Anaesthesiol. 2016;29:468–474.
   PubMed Web of Science ®Google Scholar
• Onizuka S, Tamura R, Yonaha T, et al. Clinical dose of lidocaine destroys the cell membrane and induces both necrosis and apoptosis in an identified Lymnaea neuron. J Anesth. 2012;26:54–61.
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhang P, Luo W, et al. Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69. Cancer Med. 2018;7:788–795.
   PubMed Web of Science ®Google Scholar
• Wang D, Fu L, Sun H, et al. Prostaglandin E2 promotes colorectal cancer stem cell expansion and metastasis in mice. Gastroenterology. 2015;149:1884–1895.e4.
   PubMed Web of Science ®Google Scholar
• Helander EM, Webb MP, Bias M, et al. A comparison of multimodal analgesic approaches in institutional enhanced recovery after surgery protocols for colorectal surgery: pharmacological agents. J Laparoendosc Adv Surg Tech A. 2017;27:903–908.
   PubMed Web of Science ®Google Scholar
• Memtsoudis SG, Poeran J, Zubizarreta N, et al. Association of multimodal pain management strategies with perioperative outcomes and resource utilization: a population-based study. Anesthesiology. 2018;128:891–902.
   PubMed Web of Science ®Google Scholar
• Wigmore TJ, Mohammed K, Jhanji S. Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: a retrospective analysis. Anesthesiology. 2016;124:69–79.
   PubMed Web of Science ®Google Scholar
• Austin PC. A comparison of 12 algorithms for matching on the propensity score. Statist Med. 2014;33:1057–1069.
   PubMed Web of Science ®Google Scholar
• Wu ZF, Lee MS, Wong CS, et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in colon cancer surgery. Anesthesiology. 2018;129:932–941.
   PubMed Web of Science ®Google Scholar
• Yang N, Liang Y, Yang P, et al. Propofol suppresses LPS-induced nuclear accumulation of HIF-1alpha and tumor aggressiveness in non-small cell lung cancer. Oncol Rep. 2017;37:2611–2619.
   PubMed Web of Science ®Google Scholar
• Chen X, Wu Q, You L, et al. Propofol attenuates pancreatic cancer malignant potential via inhibition of NMDA receptor. Eur J Pharmacol. 2017;795:150–159.
   PubMed Web of Science ®Google Scholar
• Liu S, Gu X, Zhu L, et al. Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer. Medicine (Baltimore). 2016;95:e5479.
   PubMed Web of Science ®Google Scholar
• Cata JP, Singh V, Lee BM, et al. Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery. J Anaesthesiol Clin Pharmacol. 2017;33:317–323.
   PubMedGoogle Scholar
• Lavon H, Matzner P, Benbenishty A, et al. Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers. Br J Anaesth. 2018;120:188–196.
   PubMed Web of Science ®Google Scholar
• Melamed R, Bar-Yosef S, Shakhar G, et al. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97:1331–1339.
   PubMed Web of Science ®Google Scholar
• Forget P, Collet V, Lavandʼhomme P, et al. Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. Eur J Anaesthesiol. 2010;27:233–240.
   PubMed Web of Science ®Google Scholar
• Wagner PL, Austin F, Zenati M, et al. Oncologic risk stratification following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal carcinomatosis. Ann Surg Oncol. 2016;23:1587–1593.
   PubMed Web of Science ®Google Scholar
• Owusu-Agyemang P, Zavala AM, Williams UU, et al. Assessing the impact of perioperative blood transfusions on the survival of adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal carcinomatosis. Vox Sang. 2017;112:567–577.
   PubMed Web of Science ®Google Scholar
• Bong TSH, Tan GHC, Chia C, et al. Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Clin Oncol. 2017;22:511–518.
   PubMed Web of Science ®Google Scholar
• Yan TD, Sim J, Morris DL. Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2007;14:1807–1817.
   PubMed Web of Science ®Google Scholar